Small- and medium-sized companies should be exposed to new technology

Domestic small- and medium-sized drug makers should focus on research and development of new drugs to survive in an era of the free trade agreements, experts said.

These firms should pursue the knowledge-intensive industry based on research and development, away from the labor-intensive industry centering on sales and marketing of unprofitable generic drugs, they said.

“The pharmaceutic...